PFE — Pfizer Inc.

Is PFE overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Pharmaceuticals

Oversold As of July 5, 2026

Pfizer Inc. (PFE) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of July 5, 2026. The Healthcare name (Pharmaceuticals) last closed at $24.32. The rating moved from Neutral to Oversold on July 3, 2026 and has changed 29 times in the last 90 days.

Public ratingOversold (as of July 5, 2026)
Last close$24.32
Rating changesRating changed 29 times in the last 90 days
Last changeMoved from Neutral to Oversold on July 3, 2026
SectorHealthcare
IndustryPharmaceuticals

Latest MarketMoodz coverage

U.S. Asking Prices Post Deepest Annual Drop Since 20172026-07-01
ADP: June Private Payrolls 98K vs 118K Estimate — Job Growth Cools2026-07-01
Innovent, Lilly Expand Verzenios Commercialization in China2026-07-01
Trump: TSMC Arizona Expansion Could Push U.S. to 50% of Chips2026-07-01
Pfizer's NSCLC ADC misses OS endpoint but shows signal in earlier-line patients2026-06-23

See today's live rating, score and targets

Members see the live hourly rating for PFE — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.